Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

AstraZeneca’s Fasenra approved by EC to treat rare inflammatory disease EGPA

Eosinophilic granulomatosis with polyangiitis affects approximately 118,000 people globally

- PMLiVE

GSK expands immunology pipeline by acquiring Chimagen’s CMG1A46 in deal worth $850m

The company plans to develop the candidate for autoimmune diseases such as lupus

- PMLiVE

UCB shares ‘encouraging’ data for Alzheimer’s disease candidate bepranemab

The drug showed benefits across key secondary endpoints, including tau accumulation

- PMLiVE

Why is storytelling changing the way we do health comms?

Principal Medical Writer, Dr Alexandra Loveday explores the importance of storytelling in health communications.

Mednet

- PMLiVE

EatMoreFruit announces launch of European PR Network

EatMoreFruit, a UK top 10 independent healthcare communication agency, today announced the launch of its European Network to support new and existing clients across the diagnostics, med tech, life sciences,...

EatMoreFruit

Journalists sat around a table participating in a media workshop

What if you could shape your next campaign messaging with the media before launch?

Sometimes you just can’t see the wood from the trees. Teams gets so focussed on the technology or treatment you’re selling that the inevitable outcome is a feature-peddling monologue where...

EatMoreFruit

- PMLiVE

Novo Nordisk’s GLP-1 drug semaglutide shows promise in fatty liver disease MASH

The company expects to file for regulatory approvals of the drug in this indication next year

- PMLiVE

LEO Pharma shares final long-term results for atopic dermatitis drug Adbry

The inflammatory skin condition affects over 26 million people in the US alone

- PMLiVE

MHRA approves CStone Pharmaceuticals’ sugemalimab to treat lung cancer in adults

Approximately 49,200 people are diagnosed with lung cancer every year in the UK

- PMLiVE

Countdown to an optimised drug launch: five determinants of success

The launch of a new pharmaceutical product depends on a host of determinants and it just takes one factor to send the launch awry

- PMLiVE

Novartis’ Scemblix granted FDA accelerated approval in newly diagnosed CML

Approximately 9,280 new cases of the disease are expected to be diagnosed in the US this year

- PMLiVE

Dermavant reports positive long-term results for Vtama cream in atopic dermatitis

More than 26 million people in the US are affected by the inflammatory skin condition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links